Cargando…
Might life-threatening acute pulmonary edema occur after using recombinant tissue plasminogen activator? A case report
BACKGROUND: Recombinant tissue plasminogen activator (rt-pa) is the first-line drug for the treatment of acute ischemic stroke, and can lead to some complications.There were rare reports of death due to acute pulmonary edema during rt-pa thrombolysis treatment. CASE PRESENTATION: This study reports...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427873/ https://www.ncbi.nlm.nih.gov/pubmed/34503474 http://dx.doi.org/10.1186/s12883-021-02371-w |